J. A. Gilmore

3.4k total citations
31 papers, 2.7k citations indexed

About

J. A. Gilmore is a scholar working on Psychiatry and Mental health, Reproductive Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, J. A. Gilmore has authored 31 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 8 papers in Reproductive Medicine and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in J. A. Gilmore's work include Schizophrenia research and treatment (13 papers), Sperm and Testicular Function (8 papers) and Reproductive Biology and Fertility (7 papers). J. A. Gilmore is often cited by papers focused on Schizophrenia research and treatment (13 papers), Sperm and Testicular Function (8 papers) and Reproductive Biology and Fertility (7 papers). J. A. Gilmore collaborates with scholars based in United States, Canada and Denmark. J. A. Gilmore's co-authors include Bruce J. Kinon, Bruce R. Basson, Gary D. Tollefson, Uriel Halbreich, John K. Critser, Hong Liu, A.T. Peter, L Kahn, Cindy C. Taylor and Keith Szymanski and has published in prestigious journals such as American Journal of Psychiatry, Gut and Human Reproduction.

In The Last Decade

J. A. Gilmore

31 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. A. Gilmore United States 22 1.2k 715 651 454 407 31 2.7k
Thomas Mills United States 29 1.5k 1.2× 477 0.7× 536 0.8× 349 0.8× 1.5k 3.7× 95 3.0k
Abdulla A.‐B. Badawy United Kingdom 36 665 0.5× 193 0.3× 159 0.2× 633 1.4× 126 0.3× 131 4.4k
Eline M. van der Beek Netherlands 40 212 0.2× 879 1.2× 424 0.7× 1.0k 2.2× 289 0.7× 148 4.9k
Beverley E. Pearson Murphy Canada 35 161 0.1× 362 0.5× 235 0.4× 570 1.3× 2.2k 5.4× 113 5.9k
Michel Pugeat France 34 127 0.1× 703 1.0× 1.4k 2.2× 182 0.4× 1.6k 3.9× 82 3.7k
Thierry Voisin France 36 607 0.5× 123 0.2× 62 0.1× 713 1.6× 183 0.4× 110 3.5k
Kabirullah Lutfy United States 29 122 0.1× 348 0.5× 177 0.3× 1.5k 3.3× 406 1.0× 103 3.8k
Patricia D. Kroboth United States 28 428 0.4× 267 0.4× 188 0.3× 146 0.3× 461 1.1× 72 2.4k
A. Vermeulen Belgium 40 467 0.4× 675 0.9× 2.2k 3.3× 609 1.3× 5.0k 12.2× 144 7.5k
Michael D. Lumpkin United States 32 129 0.1× 165 0.2× 789 1.2× 182 0.4× 739 1.8× 56 2.6k

Countries citing papers authored by J. A. Gilmore

Since Specialization
Citations

This map shows the geographic impact of J. A. Gilmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. Gilmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. Gilmore more than expected).

Fields of papers citing papers by J. A. Gilmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. Gilmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. Gilmore. The network helps show where J. A. Gilmore may publish in the future.

Co-authorship network of co-authors of J. A. Gilmore

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. Gilmore. A scholar is included among the top collaborators of J. A. Gilmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. Gilmore. J. A. Gilmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kielbasa, William, Krista M Phipps, Fanni Natanegara, et al.. (2020). A single ascending dose study in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of O‐GlcNAcase (OGA) enzyme. Alzheimer s & Dementia. 16(S9). 9 indexed citations
2.
Kinon, Bruce J., J. A. Gilmore, Hong Liu, & Uriel Halbreich. (2003). Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Psychoneuroendocrinology. 28. 55–68. 285 indexed citations
3.
Kinon, Bruce J., J. A. Gilmore, Hong Liu, & Uriel Halbreich. (2003). Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials. Psychoneuroendocrinology. 28. 69–82. 121 indexed citations
4.
Kennedy, John, Dilip V. Jeste, Christopher Kaiser, et al.. (2003). Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double‐blind controlled trial. International Journal of Geriatric Psychiatry. 18(11). 1013–1020. 30 indexed citations
5.
Willing, Marcia, Trudy L. Burns, Kathleen F. Janz, et al.. (2003). Gene polymorphisms, bone mineral density, and bone mineral content in young children: the Iowa Bone Development Study. Osteoporosis International. -1(1). 1–1. 6 indexed citations
6.
Tohen, Mauricio, Robert W. Baker, Lori L. Altshuler, et al.. (2002). Olanzapine Versus Divalproex in the Treatment of Acute Mania. American Journal of Psychiatry. 159(6). 1011–1017. 187 indexed citations
7.
Halbreich, Uriel, Bruce J. Kinon, J. A. Gilmore, & L Kahn. (2002). Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology. 28. 53–67. 193 indexed citations
8.
Kennedy, John, Anthony J. Zagar, Frank P. Bymaster, et al.. (2001). The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease. International Journal of Geriatric Psychiatry. 16(S1). S24–S32. 27 indexed citations
9.
Kinon, Bruce J., et al.. (2001). Exploration of a dose-response relationship in schizophrenia with the novel antipsychotic drug olanzapine. European Neuropsychopharmacology. 11. S278–S278. 3 indexed citations
10.
11.
Kinon, Bruce J., Bruce R. Basson, J. A. Gilmore, S Malcolm, & Virginia L. Stauffer. (2000). Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine. The Journal of Clinical Psychiatry. 61(11). 833–840. 61 indexed citations
12.
13.
Woods, Erik J., J. Liu, J. A. Gilmore, et al.. (1999). Determination of Human Platelet Membrane Permeability Coefficients Using the Kedem–Katchalsky Formalism: Estimates from Two- vs Three-Parameter Fits. Cryobiology. 38(3). 200–208. 26 indexed citations
14.
Gilmore, J. A., L.E. McGann, Edward N. Ashworth, et al.. (1998). Fundamental cryobiology of selected African mammalian spermatozoa and its role in biodiversity preservation through the development of genome resource banking. Animal Reproduction Science. 53(1-4). 277–297. 56 indexed citations
15.
Gilmore, J. A., et al.. (1997). Determination of optimal cryoprotectants and procedures for their addition and removal from human spermatozoa. Human Reproduction. 12(1). 112–118. 121 indexed citations
16.
Politis, I., Nick Hidiroglou, John H. White, et al.. (1996). Effects of vitamin E on mammary and blood leukocyte function, with emphasis on Chemotaxis, in periparturient dairy cows. American Journal of Veterinary Research. 57(4). 468–471. 55 indexed citations
17.
Gilmore, J. A., Jie Du, Jun Tao, A.T. Peter, & John K. Critser. (1996). Osmotic properties of boar spermatozoa and their relevance to cryopreservation. Reproduction. 107(1). 87–95. 85 indexed citations
18.
Gilmore, J. A., L.E. McGann, Dayong Gao, et al.. (1995). Effect of Cryoprotectant Solutes on Water Permeability of Human Spermatozoa1. Biology of Reproduction. 53(5). 985–995. 175 indexed citations
19.
Politis, I., M. Hidiroglou, T.R. Batra, et al.. (1995). Effects of vitamin E on immune function of dairy cows. American Journal of Veterinary Research. 56(2). 179–184. 95 indexed citations
20.
Gilmore, J. A., et al.. (1980). Morbidity of acute pancreatitis: the effect of aprotinin and glucagon.. Gut. 21(4). 334–339. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Mills Breakdown of academic impact, for papers by Abdulla A.‐B. Badawy Breakdown of academic impact, for papers by Eline M. van der Beek Breakdown of academic impact, for papers by Beverley E. Pearson Murphy Breakdown of academic impact, for papers by Michel Pugeat Breakdown of academic impact, for papers by Thierry Voisin Breakdown of academic impact, for papers by Kabirullah Lutfy Breakdown of academic impact, for papers by Patricia D. Kroboth Breakdown of academic impact, for papers by A. Vermeulen Breakdown of academic impact, for papers by Michael D. Lumpkin
Rankless by CCL
2026